Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus

被引:24
作者
Naito, T
Ogasawara, H
Kaneko, H
Hishikawa, T
Sekigawa, I
Hashimoto, H
Maruyama, N
机构
[1] Juntendo Univ, Izu Nagaoka Hosp, Dept Med, Izu Nagaoka, Shizuoka 4102295, Japan
[2] Juntendo Univ, Sch Med, Dept Gen Med, Bunkyo Ku, Tokyo 113, Japan
[3] Juntendo Univ, Sch Med, Dept Internal Med & Rheumatol, Bunkyo Ku, Tokyo 113, Japan
[4] Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo, Japan
关键词
human endogenous retrovirus; systemic lupus erythematosus; interleukin-16; T-cell activation; T-cell anergy;
D O I
10.1023/A:1025369500466
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P15E is a specific sequence among the envelope gene (env)-encoded transmembrane proteins of exogenous and endogenous retroviruses. A synthetic peptide (CKS-17) that shows homology to this p15E region in several species of retrovirus is known to induce immune abnormalities. In this study, we examined the effect of a synthetic peptide derived from a region of human endogenous retrovirus (HERV) clone 4-1 (lambda4 - 1) similar to sequences of CKS-17 on the induction of systemic lupus erythematosus (SLE)-related immune abnormalities. Our results indicated that this peptide could induce T-cell activation and anergy in normal peripheral blood mononuclear cells, and the peptide could also promote the production of interleukins IL-6 and IL-16. These phenomena are representative immune abnormalities observed in SLE patients. Thus, our findings support the possibility that HERV acts as a pathogen in human SLE.
引用
收藏
页码:371 / 376
页数:6
相关论文
共 31 条
[1]   Interleukin 16 and its function as a CD4 ligand [J].
Center, DM ;
Kornfeld, H ;
Cruikshank, WW .
IMMUNOLOGY TODAY, 1996, 17 (10) :476-481
[2]   NEF PROTEIN OF HIV-1 HAS B-CELL STIMULATORY ACTIVITY [J].
CHIRMULE, N ;
OYAIZU, N ;
SAXINGER, C ;
PAHWA, S .
AIDS, 1994, 8 (06) :733-739
[3]   INHIBITION OF LYMPHOCYTE-PROLIFERATION BY A SYNTHETIC PEPTIDE HOMOLOGOUS TO RETROVIRAL ENVELOPE PROTEINS [J].
CIANCIOLO, GJ ;
COPELAND, TD ;
OROSZLAN, S ;
SNYDERMAN, R .
SCIENCE, 1985, 230 (4724) :453-455
[4]   Immunosuppressive retroviral peptides: Immunopathological implications for immunosuppressive influences of retroviral infections [J].
Haraguchi, S ;
Good, RA ;
Cianciolo, GJ ;
Engelman, RW ;
Day, NK .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (06) :654-666
[5]  
HARRIS DT, 1987, J IMMUNOL, V138, P889
[6]   Retroviruses and systemic lupus erythematosus [J].
Herrmann, M ;
Hagenhofer, M ;
Kalden, JR .
IMMUNOLOGICAL REVIEWS, 1996, 152 :145-156
[7]   Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases [J].
Hishikawa, T ;
Ogasawara, H ;
Kaneko, H ;
Shirasawa, T ;
Matsuura, Y ;
Sekigawa, I ;
Takasaki, Y ;
Hashimoto, H ;
Hirose, S ;
Handa, S ;
Nagasawa, R ;
Maruyama, N .
VIRAL IMMUNOLOGY, 1997, 10 (03) :137-147
[8]   HLA-DP+ T-CELLS AND DEFICIENT INTERLEUKIN-2 PRODUCTION IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
HISHIKAWA, T ;
TOKANO, Y ;
SEKIGAWA, I ;
ANDO, S ;
TAKASAKI, Y ;
HASHIMOTO, H ;
HIROSE, S ;
OKUMURA, K ;
ABE, M ;
SHIRAI, T .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 55 (02) :285-296
[9]  
HORWITZ DA, 1997, LUPUS ERYTHEMATOSUS, P155
[10]  
KALDEN JR, 1994, CLIN EXP IMMUNOL, V98, P1, DOI 10.1111/j.1365-2249.1994.tb06597.x